http://www.pharmabiz.com/NewsDetails.aspx?aid=144524&sid=1
Rising rate of cardiovascular diseases (CVDs) and changing dietary
habits have led to growth of Omega-3 fatty acids market in India and
worldwide.
According to the American Medical Association, heart
disease was the most significant cause of mortality with 690,882 deaths.
The Food and Drug Administration has approved Omega-3 supplements to
treat disorders such as severe hypertriglyceridemia in adults. The FDA
has also approved Epanova and Omtryg, which contain eicosapentaenoic
acid (EPA)/docosahexaenoic acid (DHA) and dietary supplements.
The
global Omega 3 market was assessed at US$ 2.10 billion in 2020, with a
compound annual growth rate (CAGR) of 7.8 per cent predicted from 2020
to 2028. The increased importance of immunity development after the
Covid-19 pandemic has reinforced the market's driving force, said Dr
Sanjay Agrawal, leading pharmaceutical consultant.
The infant
formula segment is predicted to increase at the quickest CAGR throughout
the forecast period, owing to rising demand for packaged baby nutrition
products as the working population grows. The nervous system, vision,
brain, and overall growth of an infant are all aided by Omega-3 DHA, he
said.
.
Omega -3 –fatty acids have been referred to as essential
fatty acids, as they cannot be synthesized in the body and hence have to
be supplemented externally.
Omega-3 fatty acids are indicated
in hypertriglyceridemia/hyperlipidemia and associated clinical
conditions such as pre-existing coronary artery disease, post-myocardial
infarction, post coronary artery bypasses surgery/revascularization
procedures etc. They are beneficial in inflammatory and autoimmune
disorders, e.g. rheumatoid arthritis, psoriasis, etc.
“The
product demand is predicted to rise as more Omega 3 elements are
included in the diet to support heart and brain health. Sedentary
lifestyles, the work-from-home tendency, and a lack of physical
activity, especially among people in their 30s and 40s, are predicted to
drive growing product demand. Furthermore, rising consumer investment
in healthcare and well-being is expected to propel the industry
forward,” stated Dr Agrawal.
Due to the expanding product
application breadth in medicines, an increasing number of Omega 3-based
pharmaceutical product launches by market participants is likely to
boost the market growth, he added.
For example, BASF Nutrition
and Health, in collaboration with Ideogen, developed an Omega 3 product
to treat non-alcoholic fatty liver disease (NAFLD), a chronic illness,
in November 2019.
Manufacturers are aggressively adopting modern
manufacturing technologies. To ensure optimal delivery of the healthful
properties of fish oil, manufacturers focus on the effective removal of
environmental pollutants from fish oil, limiting oxidation in the
production process, and concentrating the Omega 3 content in the final
product. Smartfish, for example, has developed manufacturing procedures
that prevent oil from oxidizing and give high-temperature tolerance, he
quipped.
“Krill oil is a possible source of Omega 3. It is
becoming more popular due to its superior qualities, such as increased
water solubility and faster absorption in the human body after
consumption than traditional fish oil. Players are concentrating their
efforts on obtaining krill oil through efficient methods. Enzymotec, for
example, uses Multi-Stage Oil (MSO) extraction technology to make krill
oil, which has been clinically demonstrated to be more effective than
fish oil at increasing Omega 3 levels in human blood,” stated the
pharmaceutical consultant.
Because of the growing trend of
vegetarianism, manufacturers are focused on non-fish sources for
extracting Omega 3. Companies are increasingly looking into algal
sources since Omega 3 extracted from algae has no fishy flavour or odor,
making it an acceptable alternative for the vegan community. Polaris
introduced Omegavie DHA 800 oil, which is derived from the microalgae
Schizochytrium sp., in June 2021. The oil has a high concentration of
DHA, about 800 mg/g, which can be utilized to make vegan DHA capsules or
tablets. As per the latest updates, from 2020 to 2028, the global Omega
3 market is predicted to increase at a compound yearly growth rate of
7.8 per cent, reaching US$ 3.82 billion, he summed up.
Comments